References
- Braunschweig F, Cowie MR, Auricchio A. What are the costs of heart failure? Europace 2011;13:ii13-17
- Heidenreich PA, Albert NM, Allen LA, et al. Forecasting the impact of heart failure in the United States: a policy statement from the American Heart Association. Circ Heart Fail 2013;6:606-19
- Neaton JD, Gray G, Zuckerman BD, et al. Key issues in end point selection for heart failure trials: composite end points. J Card Fail 2005;11:567-75
- Skali H, Pfeffer MA, Lubsen J, et al. Variable impact of combining fatal and nonfatal end points in heart failure trials. Circulation 2006;114:2298-303
- McAlister FA. The ‘number needed to treat’ turns 20 – and continues to be used and misused. CMAJ 2008;179:549-53
- Halpin DMG. Evaluating the effectiveness of combination therapy to prevent COPD exacerbations: the value of NNT analysis. Int J Clin Pract 2005;59:1187-94
- Rogers JK, McMurray JJV, Pocock SJ, et al. Eplerenone in patients with systolic heart failure and mild symptoms: analysis of repeat hospitalizations. Circulation 2012;126:2317-23
- Rogers JK, Pocock SJ, McMurray JJV, et al. Analysing recurrent hospitalizations in heart failure: a review of statistical methodology, with application to CHARM-Preserved. Eur J Heart Fail 2014;16:33-40
- Rogers JK, Jhund PS, Perez A, et al. Effect of rosuvastatin on repeat heart failure hospitalizations: the CORONA trial (Controlled Rosuvastatin Multinational Trial in Heart Failure). JACC: Heart Failure 2014;2:289-97
- Swedberg K, Komajda M, Böhm M, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): a randomized placebo-controlled study. Lancet 2010;376:875-85
- Borer JS, Böhm M, Ford I, et al. Effect of ivabradine on recurrent hospitalization for worsening heart failure in patients with chronic systolic heart failure: the SHIFT Study. Eur Heart J 2012;33:2813-20
- Cook RJ. Number needed to treat for recurrent events. J Biomet Biostat 2013;4:1-6
- Ghosh D, Lin DY. Nonparametric analysis of recurrent events and death. Biometrics 2000;56:554-62
- Greenwood M, Yule GU. An inquiry into the nature of frequency distributions representative of multiple happenings with particular reference to the occurrence of multiple attacks of disease or of repeated accidents. J Roy Stat Soc 1920;83:255-79
- Böhm M, La Rosée K, Schmidt U, et al. Force–frequency relationship and inotropic stimulation in the nonfailing and failing human myocardium: implications for the medical treatment of heart failure. Clin Investig 1992;70:421-5
- Stewart S, Jenkins A, Buchan S, et al. The current cost of heart failure to the National Health Service in the UK. Eur J Heart Fail 2002;4:361-71